| 2.75 0.98 (55.37%) | 06-23 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term | |
|||
| Targets | 6-month : | 4.37 |
1-year : | 5.11 |
| Resists | First : | 3.74 |
Second : | 4.37 |
| Pivot price | 1.94 |
|||
| Supports | First : | 2.43 |
Second : | 1.62 |
| MAs | MA(5) : | 2.01 |
MA(20) : | 1.92 |
| MA(100) : | 2.32  |
MA(250) : | 2.91 |
|
| MACD | MACD : | 0 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 32.7 |
D(3) : | 31.6 |
| RSI | RSI(14): 74.3 |
|||
| 52-week | High : | 6.46 | Low : | 1.62 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.[ HSCS ] has closed above the upper band by 37.1%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 101% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 0 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 3.75 - 3.77 | 3.77 - 3.79 |
| Low: | 2.48 - 2.49 | 2.49 - 2.51 |
| Close: | 2.73 - 2.75 | 2.75 - 2.77 |
HeartSciences Inc. is a medical technology company dedicated to augmenting the clinical utility of electrocardiograms (ECGs) by integrating artificial intelligence (AI). The firm develops AI-enhanced ECG (AI-ECG) solutions, including an algorithm specifically designed to detect impaired cardiac relaxation or other forms of cardiac dysfunction, whether caused by heart disease or the natural aging process. Among its offerings is the MyoVista wavECG device, a 12-lead resting ECG that provides comprehensive diagnostic information concerning cardiac function alongside conventional ECG data in a single examination. Furthermore, the company offers MyoVista Insights, a cloud-based platform capable of hosting its AI-ECG algorithms across various ECG hardware systems. Established in 2007, HeartSciences Inc. operates from its headquarters in Southlake, Texas. The company was formerly named Heart Test Laboratories, Inc. until its rebranding to HeartSciences Inc. in October 2024.
Tue, 23 Jun 2026
Fortitude all-stock merger to shift HeartSciences (NASDAQ: HSCS) into Zcash - Stock Titan
Tue, 23 Jun 2026
Zcash Miner Fortitude Merging with HeartSciences to Go Public - Yahoo Finance Singapore
Tue, 23 Jun 2026
HeartSciences Surges on Planned Merger With Zcash Mining Platform Fortitude - Quiver Quantitative
Tue, 23 Jun 2026
HSCS Stock Pops As European Patent Expands AI Heart Tech - StocksToTrade
Tue, 23 Jun 2026
HSCS Stock Slides As HeartSciences Wins Key European Patent - timothysykes.com
Tue, 23 Jun 2026
Zcash miner Fortitude to take over HeartSciences (HSCS) in all-stock deal - Stock Titan
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | 0 (M) |
| Shares Float | 3 (M) |
| Held by Insiders | 3.07e+006 (%) |
| Held by Institutions | 2.3 (%) |
| Shares Short | 32 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | -7.77e+006 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | -89 % |
| Return on Assets (ttm) | 939.5 % |
| Return on Equity (ttm) | -73.6 % |
| Qtrly Rev. Growth | 8670 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | -194.08 |
| EBITDA (p.s.) | 2548.22 |
| Qtrly Earnings Growth | -4.5 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | -7 (M) |
| PE Ratio | -0.01 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | -0.02 |
| Price to Cash Flow | 6.52 |
| Dividend | 0 |
| Forward Dividend | 43410 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|